We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$97.6B
AUM Growth
+$13.8B
Cap. Flow
+$6.88B
Cap. Flow %
7.05%
Top 10 Hldgs %
24.85%
Holding
8,027
New
582
Increased
3,285
Reduced
3,349
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 5.21%
2 Financials 5.16%
3 Technology 4.66%
4 Consumer Discretionary 3.61%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTI
7101
CALL
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$4K ﹤0.01%
400
-5,400
-93% -$55.1K
LNBB
7102
DELISTED
L N B BANCORP INC
LNBB
$4K ﹤0.01%
+400
New +$3.93K
ESBF
7103
DELISTED
E S B FINL CORP
ESBF
$4K ﹤0.01%
286
+158
+123% +$2.13K
NOVB
7104
DELISTED
NORTH VALLEY BANCORP-COM
NOVB
$4K ﹤0.01%
200
+100
+100% +$1.91K
NASB
7105
DELISTED
NASB FINL INC
NASB
$4K ﹤0.01%
143
+101
+240% +$2.78K
CADX
7106
PUT
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$4K ﹤0.01%
400
-4,400
-92% -$31.8K
FLOW
7107
DELISTED
FLOW INTL CORP
FLOW
$4K ﹤0.01%
1,076
-3,522
-77% -$14.1K
AMNB
7108
DELISTED
American National Bankshares Inc
AMNB
$4K ﹤0.01%
179
+100
+127% +$2.38K
OMED
7109
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$4K ﹤0.01%
145
-120
-45% -$2.2K
GFA
7110
PUT
DELISTED
Gafisa S.A.
GFA
$4K ﹤0.01%
89
-1,394
-94% -$56.1K
AIXG
7111
CALL
DELISTED
Aixtron SE
AIXG
$4K ﹤0.01%
300
-1,000
-77% -$14.2K
ARP
7112
PUT
DELISTED
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
$4K ﹤0.01%
180
AGIO icon
7113
Agios Pharmaceuticals
AGIO
$1.79B
$3K ﹤0.01%
169
-217
-56% -$4.95K
BHB icon
7114
Bar Harbor Bankshares
BHB
$665M
$3K ﹤0.01%
203
+111
+121% +$1.86K
BLUE
7115
DELISTED
bluebird bio
BLUE
$3K ﹤0.01%
13
-32
-71% -$8.94K
CCBG icon
7116
Capital City Bank Group
CCBG
$888M
$3K ﹤0.01%
274
+150
+121% +$1.8K
CFFI icon
7117
C&F Financial
CFFI
$268M
$3K ﹤0.01%
72
+38
+112% +$1.92K
CORT icon
7118
Corcept Therapeutics
CORT
$12.4B
$3K ﹤0.01%
1,182
-812
-41% -$1.64K
CVGI icon
7119
Commercial Vehicle Group
CVGI
$154M
$3K ﹤0.01%
575
-124
-18% -$941
CYTK icon
7120
Cytokinetics
CYTK
$10.5B
$3K ﹤0.01%
590
-281
-32% -$1.85K
ESSA
7121
DELISTED
ESSA Bancorp
ESSA
$3K ﹤0.01%
290
+179
+161% +$1.96K
EWC icon
7122
PUT
iShares MSCI Canada ETF
EWC
$6.13B
$3K ﹤0.01%
100
-2,900
-97% -$83.9K
FARM
7123
DELISTED
Farmer Brothers
FARM
$3K ﹤0.01%
131
-91
-41% -$1.73K
FNLC icon
7124
First Bancorp
FNLC
$396M
$3K ﹤0.01%
211
+117
+124% +$2.02K
HI
7125
CALL
DELISTED
Hillenbrand
HI
$3K ﹤0.01%
100
-100
-50% -$2.85K

Similar funds

Barclays's Q4 2013 Portfolio in Review

As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.

  • Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
  • Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
  • Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
  • Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
  • Barclays opened 582 new positions and closed 442 in Q4 2013.
  • Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.